1. P399 Vedolizumab therapy results in reduced hospitalisation and steroid use over 1-year: Results from the Scottish vedolizumab consortium. (16th January 2018) Authors: Plevris, N; Chuah, C S; Allen, R; Baker, P; Brennan, P; Churchhouse, A; Donoghue, E; Gaya, D; Jafferbhoy, H; Jenkinson, P; Jones, G; Macdonald, J; MacMaster, M; Mowat, C; Naismith, G; Potts, L; Saffouri, E; Seenan, J P; Sengupta, A; Shasi, P Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PWE-045 Vedolizumab results in reduced hospitalisation and steroid use over 1-year:results from the scottish vedolizumab cohort. (8th June 2018) Authors: Plevris, Nikolas; Chuah, Cher; Jenkinson, Phil; Allen, R; Baker, P; Brennan, Paul; Churchhouse, Antonia; Din, S; Donoghue, Emma; Gaya, Daniel; Groome, Max; Jafferbhoy, H; Jones, G; Macdonald, Jonathan; MacMaster, Morag; Mowat, Craig; Naismith, G; Noble, C; Potts, L; Saffouri, E Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PWE-058 Outcomes of using therapeutic drug monitoring to guide switching from originator infliximab to biosimilar infliximab. (17th June 2017) Authors: Veryan, J; Pexton, J; Boulton-Jones, R; Clarke, A; Curry, G; Nowell, E; Macdonald, J; Seenan, JP Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗